About a dozen lawsuits, citing 2024 studies, allege Ozempic causes a rare eye disorder that leads to irreversible blindness. ...

A Maryland man has filed a lawsuit against the manufacturers of Ozempic, alleging that his use of the drug led to him ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...

Novo Nordisk faces a suit claiming it failed to warn users of Ozempic of the danger of blindness. The suit is brought by a ...

Novo Nordisk, the maker of Ozempic, prices each pen at $997.58, regardless of strength — ranging from 0.25 to 2 milligrams (mg). The total cost of Ozempic can vary depending on the dosage ...

The Food and Drug Administration had determined there is no longer a shortage of drugs like Ozempic and Wegovy, therefore it had set ending dates for the use of the compounded prescriptions made of ...

“Patients on GLP-1 medications such as Ozempic often experience rapid weight ... “In younger patients and more mild cases where the skin elasticity remains reasonably strong, fillers tend ...

Novo Nordisk (NVO) won a key case Thursday to stop some compounding ... semaglutide — the active ingredient in diabetes drug Ozempic and weight-loss drug Wegovy — next month.